Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

8.50
Delayed Data
As of Aug 28
 +0.13 / +1.55%
Today’s Change
7.46
Today|||52-Week Range
14.00
-7.71%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close8.37
Today’s open8.34
Day’s range8.34 - 8.50
Volume2,072
Average volume (3 months)4,240
Market cap$215.8M
Dividend yield--
Data as of 4:00pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-28.89%
Earnings growth (this year)-43.28%
Earnings growth (next 5 years)--
Revenue growth (last year)-17.46%
P/E ratio--
Price/Sales16.06
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
IKNXIkonics Corp0.000.00%
OCIPOCI Partners LP-0.29-2.33%
CCMPCabot Microelectroni...+0.14+0.32%
KYTHKYTHERA Biopharmaceu...+0.01+0.01%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$14.5M
Annual profit (last year)-$14.5M
Net profit margin-100.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Financial Officer
Sigal Fattal
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Partner Offers